Clinical Trial Update: Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating allogeneic mesenchymal stem cells for graft-versus-host disease; the current status of the trial is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Graft-Versus-Host Disease | Phase 1, Phase 2 | Status: UNKNOWN